Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes

Diabetes - United States
doi 10.2337/db12-0746
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Diabetes Association

Related search

FDA Urges "Black Box" Warning on Pediatric Antidepressants

CMAJ
Medicine
2004English

The Suicide Epidemic in Youth and the FDA Black-Box Warning: Time to Reconsider

Psychiatric Annals
PsychiatryMental Health
2020English

Impact of FDA Black Box Warning on Fluoroquinolone and Alternative Antibiotic Use in Southeastern US Hospitals

Infection Control and Hospital Epidemiology
EpidemiologyInfectious DiseasesMicrobiology
2019English

Ticagrelor in Patients With Stable Coronary Disease and Diabetes

New England Journal of Medicine
Medicine
2019English

The FDA Black Box Warning Does Reduce the Use of Erythropoietin Stimulating Agents and Increases Blood Transfusions in Insured, Low Income Cancer Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Minimal Change Disease Associated With High-Dose Aspirin

Cureus
2018English

Regional Rainfall Warning System for Landslides With Creep Deformation in Three Gorges Using a Statistical Black Box Model

Scientific Reports
Multidisciplinary
2019English

Ticagrelor Pharmacokinetics and Pharmacodynamics in Patients With NSTEMI After a 180-Mg Loading Dose

Platelets
MedicineHematology
2017English

Association of Aspirin Use With Major Bleeding in Patients With and Without Diabetes

JAMA - Journal of the American Medical Association
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy